Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche Inks A Second Deal With PTC Therapeutics, Pays $30M Upfront

This article was originally published in The Pink Sheet Daily

Executive Summary

The Big Pharma teams up with a biotech and a patient advocacy foundation to develop treatments for a rare genetic disorder.


Related Content

PTC Adds To Management Team In Sign Of Progress Beyond Setbacks
Isis Moves SMA Drug Forward As Market Interest For The Rare Disease Expands
Deals of the Week: Sanofi/Joslin; Merck/Ambrx; Genentech/AC Immune; GSK/Liquidia; Roche/Seaside
Biogen Strikes A Deal With Isis For Antisense Technology
AstraZeneca Digs For GEMS In Discovery Deal With PTC
A Pair Of GEMS: PTC Unveils Two Platform-Based Deals In One Day
PTC Taps Genzyme’s Global Reach, Pocketbook In Ultra-orphan Licensing Deal
PTC Advances Cystic Fibrosis Candidate On Encouraging Data


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts